Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.24M Buy
8,944
+337
+4% +$115K 1.11% 27
2026
Q1
$3.03M Sell
8,607
-936
-10% -$334K 1.26% 27
2025
Q4
$3.12M Sell
9,543
-63
-0.7% -$20K 1.26% 28
2025
Q3
$2.71M Buy
9,606
+50
+0.5% +$14.5K 1.14% 31
2025
Q2
$2.67M Buy
9,556
+132
+1% +$37.4K 1.22% 31
2025
Q1
$2.94M Sell
9,424
-186
-2% -$54.9K 1.54% 25
2024
Q4
$2.5M Sell
9,610
-65
-0.7% -$19.3K 1.21% 29
2024
Q3
$3.12M Buy
9,675
+24
+0.2% +$7.85K 1.55% 24
2024
Q2
$3.02M Buy
9,651
+128
+1% +$37.6K 1.57% 27
2024
Q1
$2.71M Buy
9,523
+26
+0.3% +$7.61K 1.49% 29
2023
Q4
$2.74M Buy
9,497
+440
+5% +$120K 1.72% 26
2023
Q3
$2.43M Sell
9,057
-145
-2% -$36.2K 1.87% 26
2023
Q2
$2.04M Sell
9,202
-253
-3% -$58.7K 1.53% 27
2023
Q1
$2.29M Buy
9,455
+4,596
+95% +$1.13M 2% 22
2022
Q4
$1.28M Sell
4,859
-2,992
-38% -$802K 1.29% 26
2022
Q3
$1.77M Sell
7,851
-274
-3% -$66.4K 1.77% 23
2022
Q2
$1.98M Sell
8,125
-192
-2% -$47K 1.76% 24
2022
Q1
$2.01M Sell
8,317
-17
-0.2% -$3.91K 1.45% 28
2021
Q4
$1.88M Buy
8,334
+1,069
+15% +$226K 1.15% 35
2021
Q3
$1.54M Buy
7,265
+388
+6% +$89.3K 1.05% 35
2021
Q2
$1.68M Buy
6,877
+56
+0.8% +$13.8K 1.19% 33
2021
Q1
$1.7M Buy
6,821
+188
+3% +$44.9K 1.32% 29
2020
Q4
$1.52M Sell
6,633
-65
-1% -$15K 1.28% 27
2020
Q3
$1.7M Buy
6,698
+285
+4% +$70.6K 1.6% 24
2020
Q2
$1.51M Buy
6,413
+74
+1% +$16.9K 1.57% 24
2020
Q1
$1.28M Sell
6,339
-75
-1% -$16.4K 1.82% 22
2019
Q4
$1.55M Buy
+6,414
New +$1.41M 1.5% 23

Other funds holding AMGN

Bay Rivers Group's AMGN Position: Q2 2026 in Review

Bay Rivers Group increased its Amgen (AMGN) stake by 3.9% in Q2 2026, buying an estimated $115K and bringing the position to 8,944 shares worth $3.24M. The position accounts for 1.11% of the portfolio, ranked #27.

Bay Rivers Group first reported a position in AMGN in Q4 2019 and has held it in 27 quarters since. 1,487 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Bay Rivers Group held 8,944 shares of Amgen worth $3.24M as of Q2 2026.
  • Bay Rivers Group bought 337 Amgen shares in Q2 2026, an estimated $115K.
  • Amgen made up 1.11% of Bay Rivers Group's portfolio in Q2 2026, its #27 holding.
  • Bay Rivers Group first reported a position in Amgen in Q4 2019 and has held it in 27 quarters since.
  • 1,487 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Bay Rivers Group's 13F filing for Q2 2026, filed 9 Jul 2026.